Single Cell Analysis Market Size To Reach USD 6.98 Billion By 2027 With Top Players Like General Electric Company, Fluidigm Corporation, NanoString Technologies, etc

May 14 03:56 2021
Single Cell Analysis Market Size To Reach USD 6.98 Billion By 2027 With Top Players Like General Electric Company, Fluidigm Corporation, NanoString Technologies, etc

Reports And Data
The increasing biopharmaceutical and biotechnology industries and the rising technological developments in single-cell analysis products are driving the demand for the market. Single Cell Analysis Market Size – USD 2.09 Billion in 2019, Market Growth – CAGR of 17.2%, Market Trends –rise in cancer prevalence globally.

The global Single Cell Analysis Market is forecasted to reach USD 6.98 Billion by 2027, according to a new report by Reports and Data. The global Single-Cell Analysis market is forecasted to expand exponentially owing to the increasing biopharmaceutical and biotechnology industries. Furthermore, the market is also anticipated to be driven by the rising technological developments in single-cell analysis products in the forecasted timeline.

The rising prevalence of cancer globally is anticipated to propel the market growth to a certain extent in the forecasted timeline. One of the biggest causes of death globally is cancer. In the past couple of decades, the condition has undergone substantial growth and is projected to increase exponentially over the forecast timeframe. In 2018, approximately 1,735,350 new cancer cases were identified in the U. S., as per the National Institutes of Health (NIH), and 609,640 individuals died from the disease. Circulatory tumor cells are gaining growing therapeutic attention because they are essential to induce cancer development to be tracked and care modified. In these situations, single-cell sequencing has been used to pursue improved diagnostic and prognostic genetic markers.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3716

The COVID-19 impact:
The distribution of Covid-19’s has influenced industrial activities worldwide. Over the weeks, the market has experienced a downturn that can continue in the coming months. The virus led to the implementation of lockdown, which disrupted the asset management program’s workings as the healthcare sector witnessed a collapse in several countries. They were loaded with patients infected by a coronavirus. Millions of people were infected, and thousands of them died, including the healthcare staff. Although the market suffered a significant setback at the time, the industry is bouncing back as there is a greater need for better management and upgrading the medical sector.

Further key findings from the report suggest

  • The cancer segment is expected to dominate the market with a CAGR of 17.4% in the forecasted timeline. Single-cell research effectively addresses the data resolution problems, and a detailed description of tumor development, metastasis, immune evasion, and antibiotic resistance has been produced. These variables have contributed to the considerable adoption of this technology in molecular genetics, leading to this segment’s anticipated prominence.
  • The flow cytometry segment is anticipated to be gradually growing over the expected timeframe. The segment’s growth is due to the commonly used flow cytometry in the identification and calculation of cell or particle occupants’ physical and chemical characteristics.
  • The Asia Pacific is anticipated to experience the fastest growth in the Single Cell Analysis market, owing to growing biotechnology funding by suppliers and clients. The Single Cell Analysis market in the region is also spurred by increasing demand for biopharmaceuticals and rising R&D activities in the biopharmaceutical industry.
  • Key participants include General Electric Company, Fluidigm Corporation, NanoString Technologies, Inc., Fluxion Biosciences Inc, Luminex Corporation, Tecan Group Ltd., Promega Corporation, Becton, Dickinson and Company, Silicon Biosystems Menarini, Inc., Illumina, Inc., among others.

Buy Now: https://www.reportsanddata.com/checkout-form/3716

For the purpose of this report, Reports and Data has segmented into the Global Single Cell Analysis Market on the basis of product, type, application, end-user, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)

  • Instruments
    • Hemocytometers
    • Flow cytometers
    • Manual Instruments
    • Automated Instruments
    • Automated Instruments
    • Cell Microarrays
    • PCR Systems
    • Microscopes
    • Automated Cell Counters
  • Consumables
    • Assay Kits
    • Reagents
    • Others

Type Outlook (Revenue, USD Billion; 2017-2027)

  • Animal
  • Human
  • Microbial

Technique Outlook (Revenue, USD Billion; 2017-2027)

  • Microscopy
  • Flow Cytometry
  • Polymerase Chain Reaction
  • Mass Spectrometry
  • Next-Generation Sequencing
  • Others

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Stem cell
  • Cancer
  • Neurology
  • In-vitro fertilization
  • Immunology
  • Non-invasive prenatal diagnosis

End-User Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals & Diagnostic Laboratories
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Laboratories
  • Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • MEA
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • Latin America
    • Brazil
    • Rest of LATAM

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/single-cell-analysis-market

Table Of Content:

Chapter 1.    Market Synopsis
    1.1.    Market Definition
    1.2.    Research Scope & Premise
    1.3.    Methodology
    1.4.    Market Estimation Technique
Chapter 2.    Executive Summary
    2.1.    Summary Snapshot, 2019-2027
Chapter 3.    Indicative Metrics
Chapter 4.    Single Cell Analysis Market Segmentation & Impact Analysis
    4.1.    Single Cell Analysis Market Material Segmentation Analysis
    4.2.    Industrial Outlook
          4.2.1.    Market indicators analysis
          4.2.2.    Market drivers analysis
                  4.2.2.1.    The increasing biopharmaceutical and biotechnology industries
                  4.2.2.2.    The rising technological developments in products for single cell analysis
                  4.2.2.3.    The Increasing emphasis on personalized medicine

Chapter 11.    Competitive Landscape
    11.1.    Market Revenue Share By Manufacturers
    11.2.    Manufacturing Cost Breakdown Analysis
    11.3.    Mergers & Acquisitions
    11.4.    Market positioning
    11.5.    Strategy Benchmarking
   11.6.    Vendor Landscape
Chapter 12.     Company Profiles                    
   12.1.    General Electric Company
           12.1.1.    Company Overview
           12.1.2.    Financial Performance
           12.1.3.    Technology Insights
          12.1.4.    Strategic Initiatives
    12.2.    Fluidigm Corporation
             12.2.1.    Company Overview
             12.2.2.    Financial Performance
             12.2.3.    Technology Insights
             12.2.4.    Strategic Initiatives
    12.3.    NanoString Technologies, Inc.
            12.3.1.    Company Overview
            12.3.2.    Financial Performance
            12.3.3.    Technology Insights
            12.3.4.    Strategic Initiatives
    12.4.    Fluxion Biosciences Inc
            12.4.1.    Company Overview
            12.4.2.    Financial Performance
            12.4.3.    Technology Insights
            12.4.4.    Strategic Initiatives
     12.5.    Luminex Corporation
             12.5.1.    Company Overview
             12.5.2.    Financial Performance
             12.5.3.    Technology Insights
             12.5.4.    Strategic Initiatives
    12.6.    Tecan Group Ltd.
            12.6.1.    Company Overview
            12.6.2.    Financial Performance
            12.6.3.    Technology Insights
            12.6.4.    Strategic Initiatives
    12.7.    Promega Corporation
            12.7.1.    Company Overview
            12.7.2.    Financial Performance
            12.7.3.    Technology Insights
            12.7.4.    Strategic Initiatives

Continue…

About Us:

Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/report-detail/prostate-cancer-diagnostics-market